Texas Capital Bancshares Inc/Tx (TCBIO) Trading Income (2023 - 2026)

Texas Capital Bancshares (TCBIO) has reported Trading Income for 4 consecutive years, with $11.3 million the latest figure, recorded in Q2 2026.

• Quarterly Trading Income rose 43.28% year-over-year to $11.3 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $34.8 million (up 38.69% YoY) and the FY2025 annual result came in at $27.1 million, up 25.23% from the prior year.
• Trading Income advanced to $11.3 million in Q2 2026 per TCBIO's latest filing, from $10.3 million in the prior quarter.
• Over the last five years, Trading Income for TCBIO reached as high as $11.3 million in Q2 2026 and fell as low as $3.8 million in Q4 2023.
• A 4-year average of $6.6 million and a median of $6.0 million in 2025 frame the typical range for Trading Income.
• Annual changes were most pronounced in 2024 — Trading Income sank 32.71% — and 2026, when it jumped 72.6%.
• Year by year, Trading Income stood at $3.8 million in 2023, then surged by 43.68% to $5.5 million in 2024, then increased by 9.71% to $6.0 million in 2025, then soared by 87.92% to $11.3 million in 2026.
• According to Business Quant data, Trading Income over the past three periods registered $11.3 million, $10.3 million, and $6.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.